JPWO2020186291A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020186291A5 JPWO2020186291A5 JP2021555436A JP2021555436A JPWO2020186291A5 JP WO2020186291 A5 JPWO2020186291 A5 JP WO2020186291A5 JP 2021555436 A JP2021555436 A JP 2021555436A JP 2021555436 A JP2021555436 A JP 2021555436A JP WO2020186291 A5 JPWO2020186291 A5 JP WO2020186291A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- formula
- hydrogen
- compound
- alkenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2019900867A AU2019900867A0 (en) | 2019-03-15 | Compounds for and Methods of Treating Diseases | |
| AU2019900867 | 2019-03-15 | ||
| PCT/AU2020/050235 WO2020186291A1 (en) | 2019-03-15 | 2020-03-13 | Compounds for and methods of treating diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022525194A JP2022525194A (ja) | 2022-05-11 |
| JPWO2020186291A5 true JPWO2020186291A5 (de) | 2023-03-17 |
Family
ID=72424099
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021555436A Pending JP2022525194A (ja) | 2019-03-15 | 2020-03-13 | 疾患を治療するための化合物および疾患を治療する方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US10941143B2 (de) |
| EP (1) | EP3938364B1 (de) |
| JP (1) | JP2022525194A (de) |
| CN (1) | CN113811533A (de) |
| AU (1) | AU2020243376A1 (de) |
| CA (1) | CA3133096A1 (de) |
| ES (1) | ES2961673T3 (de) |
| WO (1) | WO2020186291A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11155547B1 (en) | 2020-06-18 | 2021-10-26 | Alterity Therapeutics Limited | Compounds for and methods of treating diseases |
| CN112662196B (zh) * | 2020-12-25 | 2022-04-22 | 浙江工业大学 | 一种咪唑并吡啶类染料及其合成方法和应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AP2006003620A0 (en) * | 2003-10-15 | 2006-06-30 | Osi Pharm Inc | Imidazopyrazine tyroshine kinase inhibitors |
| GB0403578D0 (en) * | 2004-02-18 | 2004-03-24 | Biofocus Discovery Ltd | Compounds which interact with the G-protein coupled receptor family |
| WO2008022060A2 (en) * | 2006-08-14 | 2008-02-21 | Novartis Ag | Imidazo-pyridine derivatives for modulating protein kinase activity |
| JP2011520970A (ja) | 2008-05-19 | 2011-07-21 | オーエスアイ・フアーマスーテイカルズ・インコーポレーテツド | 置換されたイミダゾピラジン類およびイミダゾトリアジン類 |
| BR112015006828A8 (pt) * | 2012-09-26 | 2019-09-17 | Univ California | composto, ou um sal farmaceuticamente aceitável do mesmo; composição farmacêutica; uso do composto; e método para modular a atividade de uma proteína ire1 |
| WO2016004254A1 (en) * | 2014-07-01 | 2016-01-07 | The Regents Of The University Of California | Combined modulation of ire1 |
-
2020
- 2020-03-13 US US16/818,641 patent/US10941143B2/en active Active
- 2020-03-13 CN CN202080034677.0A patent/CN113811533A/zh active Pending
- 2020-03-13 CA CA3133096A patent/CA3133096A1/en active Pending
- 2020-03-13 EP EP20774412.9A patent/EP3938364B1/de active Active
- 2020-03-13 ES ES20774412T patent/ES2961673T3/es active Active
- 2020-03-13 WO PCT/AU2020/050235 patent/WO2020186291A1/en unknown
- 2020-03-13 AU AU2020243376A patent/AU2020243376A1/en active Pending
- 2020-03-13 JP JP2021555436A patent/JP2022525194A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019518766A5 (de) | ||
| RU2020108515A (ru) | Соединения и способы целевого расщепления андрогенного рецептора | |
| JP2013010792A5 (de) | ||
| JP2018138577A5 (de) | ||
| JP2018528261A5 (de) | ||
| JP2019515952A5 (de) | ||
| JP2020122016A5 (de) | ||
| JP2022141835A5 (de) | ||
| RU2010136665A (ru) | Новые пиридиноны и пиридазиноны | |
| JP2019501130A5 (de) | ||
| JP2014511892A5 (de) | ||
| JP2005523922A5 (de) | ||
| JP2008509166A5 (de) | ||
| JP2012508252A5 (de) | ||
| JP2014503525A5 (de) | ||
| RU2007147344A (ru) | Новые производные 2-азетидинона для лечения гиперлипидемических заболеваний | |
| RU2005123802A (ru) | Производные адамантана, способы их получения и содержащие их фармацевтические композиции | |
| JPWO2020033828A5 (de) | ||
| JP2020507606A5 (de) | ||
| JP2020511547A5 (de) | ||
| JP2015511232A5 (de) | ||
| JP2016529315A5 (de) | ||
| JP2018524406A5 (de) | ||
| RU2018129344A (ru) | Производное хиназолинона, способ его получения, фармацевтическая композиция и применения | |
| JP2020063289A5 (de) |